These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25953319)

  • 1. Assessing upper extremity capacity as a potential indicator of needs related to household activities for rehabilitation services in people with myotonic dystrophy type 1.
    Raymond K; Auger LP; Cormier MF; Vachon C; St-Onge S; Mathieu J; Noreau L; Gagnon C
    Neuromuscul Disord; 2015 Jun; 25(6):522-9. PubMed ID: 25953319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of disrupted social participation in myotonic dystrophy type 1.
    Gagnon C; Mathieu J; Jean S; Laberge L; Perron M; Veillette S; Richer L; Noreau L
    Arch Phys Med Rehabil; 2008 Jul; 89(7):1246-55. PubMed ID: 18586127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hand-training in persons with myotonic dystrophy type 1--a randomised controlled cross-over pilot study.
    Aldehag A; Jonsson H; Lindblad J; Kottorp A; Ansved T; Kierkegaard M
    Disabil Rehabil; 2013 Oct; 35(21):1798-807. PubMed ID: 23480644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 9-year follow-up study of the natural progression of upper limb performance in myotonic dystrophy type 1: A similar decline for phenotypes but not for gender.
    Raymond K; Levasseur M; Mathieu J; Desrosiers J; Gagnon C
    Neuromuscul Disord; 2017 Jul; 27(7):673-682. PubMed ID: 28527585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functioning and disability in adults with myotonic dystrophy type 1.
    Kierkegaard M; Harms-Ringdahl K; Holmqvist LW; Tollbäck A
    Disabil Rehabil; 2011; 33(19-20):1826-36. PubMed ID: 21254917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life habits in myotonic dystrophy type 1.
    Gagnon C; Mathieu J; Noreau L
    J Rehabil Med; 2007 Sep; 39(7):560-6. PubMed ID: 17724556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1.
    Kierkegaard M; Petitclerc É; Hébert LJ; Mathieu J; Gagnon C
    J Rehabil Med; 2018 Feb; 50(3):269-277. PubMed ID: 29260836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of participation in myotonic dystrophy: reliability of the LIFE-H.
    Gagnon C; Mathieu J; Noreau L
    Neuromuscul Disord; 2006 Apr; 16(4):262-8. PubMed ID: 16545567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of participation restriction over a 9-year period in adults with myotonic dystrophy type 1.
    Raymond K; Levasseur M; Gallais B; Richer L; Laberge L; Petitclerc É; Mathieu J; Gagnon C
    Disabil Rehabil; 2022 Jun; 44(12):2615-2631. PubMed ID: 33135946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived functioning and disability in adults with myotonic dystrophy type 1: a survey according to the International Classification Of Functioning, Disability and Health.
    Kierkegaard M; Harms-Ringdahl K; Widén Holmqvist L; Tollbäck A
    J Rehabil Med; 2009 Jun; 41(7):512-20. PubMed ID: 19543661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived ability to perform daily hand activities after stroke and associated factors: a cross-sectional study.
    Ekstrand E; Rylander L; Lexell J; Brogårdh C
    BMC Neurol; 2016 Nov; 16(1):208. PubMed ID: 27806698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of disease severity on upper extremity muscle strength, exercise capacity, and activities of daily living in individuals with pulmonary arterial hypertension].
    Özcan Kahraman B; Özsoy İ; Acar S; Özpelit E; Akdeniz B; Sevinç C; Savcı S
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):434-440. PubMed ID: 28694397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between dysfunction of upper extremity and locomotive syndrome in general population.
    Tajika T; Yamamoto A; Oya N; Okura C; Shinagawa S; Kitagawa T; Kobayashi H; Iizuka H; Takagishi K
    J Orthop Sci; 2017 Jan; 22(1):144-148. PubMed ID: 27919650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1.
    Raymond K; Levasseur M; Mathieu J; Gagnon C
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1629-1639. PubMed ID: 30831092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).
    Moxley RT; Logigian EL; Martens WB; Annis CL; Pandya S; Moxley RT; Barbieri CA; Dilek N; Wiegner AW; Thornton CA
    Muscle Nerve; 2007 Sep; 36(3):320-8. PubMed ID: 17587223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal physical profile assessment of skeletal muscle manifestations in myotonic dystrophy.
    Nitz JC; Burns YR; Jackson RV
    Clin Rehabil; 1999 Feb; 13(1):64-73. PubMed ID: 10327099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of hand dominance and ulnar and median nerve impairment on strength and basic daily activities.
    Rajan P; Premkumar R; Rajkumar P; Richard J
    J Hand Ther; 2005; 18(1):40-5. PubMed ID: 15674786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial.
    Keramiotou K; Anagnostou C; Kataxaki E; Galanos A; Sfikakis PP; Tektonidou MG
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.
    Roussel MP; Fiset MM; Gauthier L; Lavoie C; McNicoll É; Pouliot L; Gagnon C; Duchesne E
    J Neurol; 2021 Nov; 268(11):4221-4237. PubMed ID: 33907889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
    Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
    J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.